506365 STARSOURCE

Starsource Multitrade Share Price

 

 

Start SIP in STARSOURCE

Start SIP

Performance

  • Low
  • ₹124
  • High
  • ₹125
  • 52 Week Low
  • ₹63
  • 52 Week High
  • ₹154
  • Open Price₹125
  • Previous Close₹125
  • Volume53

Investment Returns

  • Over 1 Month -0.88%
  • Over 3 Month -5.11%
  • Over 6 Month -1.35%
  • Over 1 Year + 53.1%

Smart Investing Starts Here Start SIP with Starsource Multitrade for Steady Growth!

Invest Now

Starsource Multitrade Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.5
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 19
  • P/B Ratio
  • 1.4
  • Average True Range
  • 11.18
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.32
  • RSI
  • 51.7
  • MFI
  • 60.04

Starsource Multitrade Financials

Starsource Multitrade Technicals

EMA & SMA

Current Price
₹124.30
-0.7 (-0.56%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹122.39
  • 50 Day
  • ₹122.90
  • 100 Day
  • ₹122.28
  • 200 Day
  • ₹115.56

Resistance and Support

124.5 Pivot Speed
  • R3 125.30
  • R2 125.10
  • R1 124.70
  • S1 124.10
  • S2 123.90
  • S3 123.50

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Starsource Multitrade Ltd has an operating revenue of Rs. 1.22 Cr. on a trailing 12-month basis. An annual revenue de-growth of -66% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 17% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Starsource Multitrade Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-22 Others Inter-alia, to consider 1. Request letter dated 11/08/2025 received for reclassification of the status by Ms. Shanta Somani from "Promoter Group Shareholder" to "Public Shareholder"
2025-08-12 Quarterly Results & A.G.M.
2025-07-31 Others Inter-alia 1. To consider and accept resignation of existing statutory auditors. 2. To appoint fresh statutory auditors to fill the casual vacancy.
2025-05-29 Audited Results

Starsource Multitrade F&O

Starsource Multitrade Shareholding Pattern

27.89%
0.17%
65.66%
6.28%

About Starsource Multitrade

  • NSE Symbol
  • STARSOURCE
  • BSE Symbol
  • 506365
  • Managing Director & CEO
  • Mr. Ruchit Mehta
  • ISIN
  • INE320M01019

Similar Stocks to Starsource Multitrade

Starsource Multitrade FAQs

Starsource Multitrade share price is ₹124 As on 15 November, 2025 | 07:59

The Market Cap of Starsource Multitrade is ₹18.6 Cr As on 15 November, 2025 | 07:59

The P/E ratio of Starsource Multitrade is -1.5 As on 15 November, 2025 | 07:59

The PB ratio of Starsource Multitrade is 1.4 As on 15 November, 2025 | 07:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23